Since the suppressive role of Malat1 on metastatic ability of breast cancer in mouse has been reported (58), more experiments in animal studies and clinical trials are still warranted to explore the MALAT1 pathway as a therapeutic target for breast cancer. The gene discussed is MALAT1; the disease is breast carcinoma.